CEO Ian Read and former CFO Frank D’Amelio said on Wednesday evening that they will step back from activist investor ...

Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with ...

Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...

The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was ...

Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D'Amelio: We have decided not to be involved in the efforts of Starboard Value ...

With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...

Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Before March of 2022, “the whole sector was lazy because of very cheap interest rates”, said Anuj Ranjan, the chief executive of private equity at Brookfield. Ranjan added that at that time, financial ...

Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...